SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:118310228"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:118310228" > Ofatumumab (HuMax-C...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Ofatumumab (HuMax-CD20), a Novel CD20 Monoclonal Antibody, Is An Active Treatment for Patients with CLL Refractory to Both Fludarabine and Alemtuzumab or Bulky Fludarabine-Refractory Disease: Results from the Planned Interim Analysis of An International Pivotal Trial

Osterborg, A (author)
Karolinska Institutet
Kipps, TJ (author)
Mayer, J (author)
show more...
Stilgenbauer, S (author)
Williams, CD (author)
Hellmen, A (author)
Robak, T (author)
Furman, RR (author)
Hillmen, P (author)
Trneny, M (author)
Dyer, MJS (author)
Padmanabhan, S (author)
Kozak, T (author)
Chan, G (author)
Davis, RL (author)
Losic, N (author)
Russell, CA (author)
Piotrowska, M (author)
Wilms, J (author)
Wierda, WG (author)
show less...
 (creator_code:org_t)
2008
2008
English.
In: BLOOD. - 0006-4971. ; 112:11, s. 126-127
  • Conference paper (other academic/artistic)
Subject headings
Close  

Publication and Content Type

vet (subject category)
kon (subject category)

Find in a library

  • BLOOD (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view